Clinical‐histological associations in gastroparesis: results from the Gastroparesis Clinical Research Consortium
dc.contributor.author | Grover, M. | en_US |
dc.contributor.author | Bernard, C. E. | en_US |
dc.contributor.author | Pasricha, P. J. | en_US |
dc.contributor.author | Lurken, M. S. | en_US |
dc.contributor.author | Faussone‐pellegrini, M. S. | en_US |
dc.contributor.author | Smyrk, T. C. | en_US |
dc.contributor.author | Parkman, H. P. | en_US |
dc.contributor.author | Abell, T. L. | en_US |
dc.contributor.author | Snape, W. J. | en_US |
dc.contributor.author | Hasler, W. L. | en_US |
dc.contributor.author | McCallum, R. W. | en_US |
dc.contributor.author | Nguyen, L. | en_US |
dc.contributor.author | Koch, K. L. | en_US |
dc.contributor.author | Calles, J. | en_US |
dc.contributor.author | Lee, L. | en_US |
dc.contributor.author | Tonascia, J. | en_US |
dc.contributor.author | Ünalp‐arida, A. | en_US |
dc.contributor.author | Hamilton, F. A. | en_US |
dc.contributor.author | Farrugia, G. | en_US |
dc.date.accessioned | 2012-07-12T17:25:17Z | |
dc.date.available | 2013-08-01T14:04:40Z | en_US |
dc.date.issued | 2012-06 | en_US |
dc.identifier.citation | Grover, M.; Bernard, C. E.; Pasricha, P. J.; Lurken, M. S.; Faussone‐pellegrini, M. S. ; Smyrk, T. C.; Parkman, H. P.; Abell, T. L.; Snape, W. J.; Hasler, W. L.; McCallum, R. W.; Nguyen, L.; Koch, K. L.; Calles, J.; Lee, L.; Tonascia, J.; Ünalp‐arida, A. ; Hamilton, F. A.; Farrugia, G. (2012). "Clinicalâ histological associations in gastroparesis: results from the Gastroparesis Clinical Research Consortium." Neurogastroenterology & Motility 24(6). <http://hdl.handle.net/2027.42/92097> | en_US |
dc.identifier.issn | 1350-1925 | en_US |
dc.identifier.issn | 1365-2982 | en_US |
dc.identifier.uri | https://hdl.handle.net/2027.42/92097 | |
dc.description.abstract | Background Cellular changes associated with diabetic (DG) and idiopathic gastroparesis (IG) have recently been described from patients enrolled in the Gastroparesis Clinical Research Consortium. The association of these cellular changes with gastroparesis symptoms and gastric emptying is unknown. The aim of this study was to relate cellular changes to symptoms and gastric emptying in patients with gastroparesis. Methods Earlier, using full thickness gastric body biopsies from 20 DG, 20 IG, and 20 matched controls, we found decreased interstitial cells of Cajal (ICC) and enteric nerves and an increase in immune cells in both DG and IG. Here, demographic, symptoms [gastroparesis cardinal symptom index score (GCSI)], and gastric emptying were related to cellular alterations using Pearson’s correlation coefficients. Key Results Interstitial cells of Cajal counts inversely correlated with 4 h gastric retention in DG but not in IG (r = −0.6, P = 0.008, DG, r = 0.2, P = 0.4, IG). There was also a significant correlation between loss of ICC and enteric nerves in DG but not in IG (r = 0.5, P = 0.03 for DG, r = 0.3, P = 0.16, IG). Idiopathic gastroparesis with a myenteric immune infiltrate scored higher on the average GCSI (3.6 ± 0.7 vs 2.7 ± 0.9, P = 0.05) and nausea score (3.8 ± 0.9 vs 2.6 ± 1.0, P = 0.02) as compared to those without an infiltrate. Conclusions & Inferences In DG, loss of ICC is associated with delayed gastric emptying. Interstitial cells of Cajal or enteric nerve loss did not correlate with symptom severity. Overall clinical severity and nausea in IG is associated with a myenteric immune infiltrate. Thus, full thickness gastric biopsies can help define specific cellular abnormalities in gastroparesis, some of which are associated with physiological and clinical characteristics of gastroparesis. | en_US |
dc.publisher | Blackwell Publishing Ltd | en_US |
dc.publisher | Wiley Periodicals, Inc. | en_US |
dc.subject.other | Clinical Symptoms | en_US |
dc.subject.other | Macrophages | en_US |
dc.subject.other | Interstitial Cells of Cajal | en_US |
dc.subject.other | Gastroparesis | en_US |
dc.subject.other | Gastric Emptying | en_US |
dc.subject.other | Enteric Nervous System | en_US |
dc.title | Clinical‐histological associations in gastroparesis: results from the Gastroparesis Clinical Research Consortium | en_US |
dc.type | Article | en_US |
dc.rights.robots | IndexNoFollow | en_US |
dc.subject.hlbsecondlevel | Internal Medicine and Specialties | en_US |
dc.subject.hlbtoplevel | Health Sciences | en_US |
dc.description.peerreviewed | Peer Reviewed | en_US |
dc.contributor.affiliationum | University of Michigan, Ann Arbor, MI, USA | en_US |
dc.contributor.affiliationother | Mayo Clinic, Rochester, MN, USA | en_US |
dc.contributor.affiliationother | Stanford University, Palo Alto, CA, USA | en_US |
dc.contributor.affiliationother | University of Florence, Florence, Italy | en_US |
dc.contributor.affiliationother | Temple University, Philadelphia, PA, USA | en_US |
dc.contributor.affiliationother | University of Mississippi, Jackson, MS, USA | en_US |
dc.contributor.affiliationother | California Pacific Medical Center, San Francisco, CA, USA | en_US |
dc.contributor.affiliationother | Texas Tech University Health Sciences Center, TX, USA | en_US |
dc.contributor.affiliationother | Wake Forest University, Winston‐Salem, NC, USA | en_US |
dc.contributor.affiliationother | Johns Hopkins University, Baltimore, MD, USA | en_US |
dc.contributor.affiliationother | National Institute of Diabetes and Digestive and Kidney Diseases, Bethesda, MD, USA | en_US |
dc.description.bitstreamurl | http://deepblue.lib.umich.edu/bitstream/2027.42/92097/1/j.1365-2982.2012.01894.x.pdf | |
dc.identifier.doi | 10.1111/j.1365-2982.2012.01894.x | en_US |
dc.identifier.source | Neurogastroenterology & Motility | en_US |
dc.identifier.citedreference | Choi KM, Kashyap PC, Dutta N, et al. CD206‐positive M2 macrophages that express heme oxygenase‐1 protect against diabetic gastroparesis in mice. Gastroenterology 2010; 138: 2399 – 409, 409 e1. | en_US |
dc.identifier.citedreference | Gangula PR, Maner WL, Micci MA, Garfield RE, Pasricha PJ. Diabetes induces sex‐dependent changes in neuronal nitric oxide synthase dimerization and function in the rat gastric antrum. Am J Physiol Gastrointest Liver Physiol 2007; 292: G725 – 33. | en_US |
dc.identifier.citedreference | Spangeus A, Suhr O, El‐Salhy M. Diabetic state affects the innervation of gut in an animal model of human type 1 diabetes. Histol Histopathol 2000; 15: 739 – 44. | en_US |
dc.identifier.citedreference | Zarate N, Mearin F, Wang XY, Hewlett B, Huizinga JD, Malagelada JR. Severe idiopathic gastroparesis due to neuronal and interstitial cells of Cajal degeneration: pathological findings and management. Gut 2003; 52: 966 – 70. | en_US |
dc.identifier.citedreference | Parkman HP, Hasler WL, Fisher RS, American Gastroenterological Association. American Gastroenterological Association technical review on the diagnosis and treatment of gastroparesis. Gastroenterology 2004; 127: 1592 – 622. | en_US |
dc.identifier.citedreference | Camilleri M. Clinical practice. Diabetic gastroparesis. N Engl J Med 2007; 356: 820 – 9. | en_US |
dc.identifier.citedreference | Bytzer P, Talley NJ, Leemon M, Young LJ, Jones MP, Horowitz M. Prevalence of gastrointestinal symptoms associated with diabetes mellitus: a population‐based survey of 15,000 adults. Arch Intern Med 2001; 161: 1989 – 96. | en_US |
dc.identifier.citedreference | Parkman HP, Yates K, Hasler WL et al. Clinical features of idiopathic gastroparesis vary with sex, body mass, symptom onset, delay in gastric emptying, and gastroparesis severity. Gastroenterology 2011; 140: 101 – 15. | en_US |
dc.identifier.citedreference | Wang YR, Fisher RS, Parkman HP. Gastroparesis‐related hospitalizations in the United States: trends, characteristics, and outcomes, 1995–2004. Am J Gastroenterol 2008; 103: 313 – 22. | en_US |
dc.identifier.citedreference | Jung HK, Choung RS, Locke GR 3rd et al. The incidence, prevalence, and outcomes of patients with gastroparesis in Olmsted County, Minnesota, from 1996 to 2006. Gastroenterology 2009; 136: 1225 – 33. | en_US |
dc.identifier.citedreference | Vittal H, Farrugia G, Gomez G, Pasricha PJ. Mechanisms of disease: the pathological basis of gastroparesis – a review of experimental and clinical studies. Nat Clin Pract Gastroenterol Hepatol 2007; 4: 336 – 46. | en_US |
dc.identifier.citedreference | He CL, Soffer EE, Ferris CD, Walsh RM, Szurszewski JH, Farrugia G. Loss of interstitial cells of cajal and inhibitory innervation in insulin‐dependent diabetes. Gastroenterology 2001; 121: 427 – 34. | en_US |
dc.identifier.citedreference | Choi KM, Gibbons SJ, Roeder JL et al. Regulation of interstitial cells of Cajal in the mouse gastric body by neuronal nitric oxide. Neurogastroenterol Motil 2007; 19: 585 – 95. | en_US |
dc.identifier.citedreference | Pasricha PJ, Pehlivanov ND, Gomez G, Vittal H, Lurken MS, Farrugia G. Changes in the gastric enteric nervous system and muscle: a case report on two patients with diabetic gastroparesis. BMC Gastroenterol 2008; 8: 21. | en_US |
dc.identifier.citedreference | Takahashi T, Nakamura K, Itoh H, Sima AA, Owyang C. Impaired expression of nitric oxide synthase in the gastric myenteric plexus of spontaneously diabetic rats. Gastroenterology 1997; 113: 1535 – 44. | en_US |
dc.identifier.citedreference | Miller SM, Narasimhan RA, Schmalz PF et al. Distribution of interstitial cells of Cajal and nitrergic neurons in normal and diabetic human appendix. Neurogastroenterol Motil 2008; 20: 349 – 57. | en_US |
dc.identifier.citedreference | Samsom M, Bharucha A, Gerich JE et al. Diabetes mellitus and gastric emptying: questions and issues in clinical practice. Diabetes Metab Res Rev 2009; 25: 502 – 14. | en_US |
dc.identifier.citedreference | Sokol H, Lavergne‐Slove A, Mikol J, Sabate JM, Coffin B. Severe isolated myopathic gastroparesis: a case report with pathological findings. Gut 2006; 55: 1662. | en_US |
dc.identifier.citedreference | Plourde V, Quintero E, Suto G, Coimbra C, Tache Y. Delayed gastric emptying induced by inhibitors of nitric oxide synthase in rats. Eur J Pharmacol 1994; 256: 125 – 9. | en_US |
dc.identifier.citedreference | Mashimo H, Kjellin A, Goyal RK. Gastric stasis in neuronal nitric oxide synthase‐deficient knockout mice. Gastroenterology 2000; 119: 766 – 73. | en_US |
dc.identifier.citedreference | Shah V, Lyford G, Gores G, Farrugia G. Nitric oxide in gastrointestinal health and disease. Gastroenterology 2004; 126: 903 – 13. | en_US |
dc.identifier.citedreference | Costa M, Glise H, Sjodahl R. The enteric nervous system in health and disease. Gut 2000; 47: iv1. | en_US |
dc.identifier.citedreference | Koch KL. Diabetic gastropathy: gastric neuromuscular dysfunction in diabetes mellitus: a review of symptoms, pathophysiology, and treatment. Dig Dis Sci 1999; 44: 1061 – 75. | en_US |
dc.identifier.citedreference | Chen JD, Lin Z, Pan J, McCallum RW. Abnormal gastric myoelectrical activity and delayed gastric emptying in patients with symptoms suggestive of gastroparesis. Dig Dis Sci 1996; 41: 1538 – 45. | en_US |
dc.identifier.citedreference | Iwasaki H, Kajimura M, Osawa S et al. A deficiency of gastric interstitial cells of Cajal accompanied by decreased expression of neuronal nitric oxide synthase and substance P in patients with type 2 diabetes mellitus. J Gastroenterol 2006; 41: 1076 – 87. | en_US |
dc.identifier.citedreference | Ordog T, Takayama I, Cheung WK, Ward SM, Sanders KM. Remodeling of networks of interstitial cells of Cajal in a murine model of diabetic gastroparesis. Diabetes 2000; 49: 1731 – 9. | en_US |
dc.identifier.citedreference | Choi KM, Gibbons SJ, Nguyen TV et al. Heme oxygenase‐1 protects interstitial cells of Cajal from oxidative stress and reverses diabetic gastroparesis. Gastroenterology 2008; 135: 2055 – 64. | en_US |
dc.identifier.citedreference | Wang XY, Huizinga JD, Diamond J, Liu LW. Loss of intramuscular and submuscular interstitial cells of Cajal and associated enteric nerves is related to decreased gastric emptying in streptozotocin‐induced diabetes. Neurogastroenterol Motil 2009; 21: 1095 – e92. | en_US |
dc.identifier.citedreference | Farrugia G. Interstitial cells of Cajal in health and disease. Neurogastroenterol Motil 2008; 20 ( Suppl 1 ): 54 – 63. | en_US |
dc.identifier.citedreference | Kashyap P, Farrugia G. Diabetic gastroparesis: what we have learned and had to unlearn in the past 5 years. Gut 2010; 59: 1716 – 26. | en_US |
dc.identifier.citedreference | Abell TL, Camilleri M, Donohoe K et al. Consensus recommendations for gastric emptying scintigraphy: a joint report of the American Neurogastroenterology and Motility Society and the Society of Nuclear Medicine. Am J Gastroenterol 2008; 103: 753 – 63. | en_US |
dc.identifier.citedreference | Rentz AM, Kahrilas P, Stanghellini V et al. Development and psychometric evaluation of the patient assessment of upper gastrointestinal symptom severity index (PAGI‐SYM) in patients with upper gastrointestinal disorders. Qual Life Res 2004; 13: 1737 – 49. | en_US |
dc.identifier.citedreference | Grover M, Farrugia G, Lurken MS et al. Cellular changes in diabetic and idiopathic gastroparesis. Gastroenterology 2011; 140: 1575 – 85. | en_US |
dc.identifier.citedreference | Lin Z, Sarosiek I, Forster J, Damjanov I, Hou Q, McCallum RW. Association of the status of interstitial cells of Cajal and electrogastrogram parameters, gastric emptying and symptoms in patients with gastroparesis. Neurogastroenterol Motil 2010; 22: 56 – 61. | en_US |
dc.identifier.citedreference | Forster J, Damjanov I, Lin Z, Sarosiek I, Wetzel P, McCallum RW. Absence of the interstitial cells of Cajal in patients with gastroparesis and correlation with clinical findings. J Gastrointest Surg 2005; 9: 102 – 8. | en_US |
dc.identifier.citedreference | Sarnelli G, Caenepeel P, Geypens B, Janssens J, Tack J. Symptoms associated with impaired gastric emptying of solids and liquids in functional dyspepsia. Am J Gastroenterol 2003; 98: 783 – 8. | en_US |
dc.identifier.citedreference | Tack J, Bisschops R, Sarnelli G. Pathophysiology and treatment of functional dyspepsia. Gastroenterology 2004; 127: 1239 – 55. | en_US |
dc.identifier.citedreference | Cassilly DW, Wang YR, Friedenberg FK, Nelson DB, Maurer AH, Parkman HP. Symptoms of gastroparesis: use of the gastroparesis cardinal symptom index in symptomatic patients referred for gastric emptying scintigraphy. Digestion 2008; 78: 144 – 51. | en_US |
dc.identifier.citedreference | Khazen W, M’Bika J P, Tomkiewicz C et al. Expression of macrophage‐selective markers in human and rodent adipocytes. FEBS Lett 2005; 579: 5631 – 4. | en_US |
dc.identifier.citedreference | Holness CL, Simmons DL. Molecular cloning of CD68, a human macrophage marker related to lysosomal glycoproteins. Blood 1993; 81: 1607 – 13. | en_US |
dc.identifier.citedreference | Horny HP, Ruck P, Xiao JC, Kaiserling E. Immunoreactivity of normal and neoplastic human tissue mast cells with macrophage‐associated antibodies, with special reference to the recently developed monoclonal antibody PG‐M1. Hum Pathol 1993; 24: 355 – 8. | en_US |
dc.identifier.citedreference | Harberson J, Thomas RM, Harbison SP, Parkman HP. Gastric neuromuscular pathology in gastroparesis: analysis of full‐thickness antral biopsies. Dig Dis Sci 2010; 10: 359 – 70. | en_US |
dc.owningcollname | Interdisciplinary and Peer-Reviewed |
Files in this item
Remediation of Harmful Language
The University of Michigan Library aims to describe library materials in a way that respects the people and communities who create, use, and are represented in our collections. Report harmful or offensive language in catalog records, finding aids, or elsewhere in our collections anonymously through our metadata feedback form. More information at Remediation of Harmful Language.
Accessibility
If you are unable to use this file in its current format, please select the Contact Us link and we can modify it to make it more accessible to you.